{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2021", "item": "https://www.patentleaderboard.com/2021/"}, {"@type": "ListItem", "position": 3, "name": "Amgen", "item": "https://www.patentleaderboard.com/2021/company/amgen"}, {"@type": "ListItem", "position": 4, "name": "John Yeoman", "item": "https://www.patentleaderboard.com/2021/inventor/fl:jo_ln:yeoman-2"}]}

Home › 2021 › Amgen › John Yeoman

John Yeoman — 1 Patent in 2021

AMAmgen: 1 patents #129 of 505Top 30%

CYCytokinetics: 1 patents #3 of 29Top 15%

Medford, MA: #52 of 185 inventorsTop 30%

Massachusetts: #4,998 of 14,123 inventorsTop 40%

Overall (2021): #390,159 of 548,734Top 75%

1 Patents 2021

Issued Patents 2021

Showing 1–1 of 1 patents

Patent #	Title	Co-Inventors	Date	Approx Value ⓘ
10899746	Bisamide sarcomere activating compounds and uses thereof	Luke W. Ashcraft, Alessandro Boezio, John R. BUTLER, Aroop Chandra, Chihyuan Chuang +15 more	2021-01-26	$988,568,000

John Yeoman — 1 Patent in 2021

Issued Patents 2021

Patent Widget